Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 33.50
-0.95 (-2.76%)
At close: Jan 28, 2026
SHE:301263 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 12.11 | 97.04 | 153.5 | 174.61 | 120.07 | 160.83 |
Depreciation & Amortization | 53.99 | 53.99 | 39.04 | 33.07 | 28.25 | 22.65 |
Other Amortization | 1.08 | 1.08 | 0.62 | 0.76 | 1.06 | 1.59 |
Loss (Gain) From Sale of Assets | - | - | -0.15 | -0.01 | 0.02 | 0.51 |
Asset Writedown & Restructuring Costs | 1.27 | 1.27 | 7.61 | 0.3 | 3.34 | 8.11 |
Loss (Gain) From Sale of Investments | -2.9 | -2.9 | -8.5 | -9.97 | -0.27 | -0.43 |
Provision & Write-off of Bad Debts | 5.19 | 5.19 | 7.16 | 3.46 | - | - |
Other Operating Activities | 42.9 | 8.62 | 1.75 | 6.03 | 4.3 | -2.14 |
Change in Accounts Receivable | -28.87 | -28.87 | -70.77 | -64.03 | -55.86 | -63.83 |
Change in Inventory | -17.43 | -17.43 | -9.41 | -4.67 | 23.25 | -7.05 |
Change in Accounts Payable | -1.58 | -1.58 | -22.53 | 13.68 | 1.91 | -27.68 |
Change in Other Net Operating Assets | -0.54 | -0.54 | -3.47 | 0.58 | -0.58 | 19.11 |
Operating Cash Flow | 38.69 | 89.33 | 93.53 | 148.81 | 120.02 | 125.53 |
Operating Cash Flow Growth | 38.88% | -4.48% | -37.15% | 23.99% | -4.38% | 66.39% |
Capital Expenditures | -102.11 | -68.55 | -200.01 | -89.88 | -44.65 | -93.12 |
Sale of Property, Plant & Equipment | 0.02 | 0.01 | 0.09 | 0.01 | 0.1 | 0.1 |
Cash Acquisitions | - | - | -188.56 | - | - | - |
Investment in Securities | -10.67 | 129 | -11 | -263.13 | 0.27 | 0.43 |
Other Investing Activities | 2.05 | 5.8 | 8.55 | - | - | - |
Investing Cash Flow | -110.71 | 66.26 | -390.93 | -353.01 | -44.29 | -92.59 |
Short-Term Debt Issued | - | - | - | - | 107.51 | 127.01 |
Long-Term Debt Issued | - | 244.5 | 173.64 | 20 | - | 0.35 |
Total Debt Issued | 508.63 | 244.5 | 173.64 | 20 | 107.51 | 127.36 |
Short-Term Debt Repaid | - | - | - | - | -126.3 | -74.96 |
Long-Term Debt Repaid | - | -180.47 | -21.55 | -110.86 | -5.52 | - |
Total Debt Repaid | -377.04 | -180.47 | -21.55 | -110.86 | -131.82 | -74.96 |
Net Debt Issued (Repaid) | 131.6 | 64.03 | 152.09 | -90.86 | -24.31 | 52.39 |
Issuance of Common Stock | 55 | - | - | 1,078 | - | - |
Repurchase of Common Stock | - | - | -39 | - | - | - |
Common Dividends Paid | -94.46 | -135.12 | -166.78 | -85.81 | -4.27 | -68.14 |
Dividends Paid | -94.46 | -135.12 | -166.78 | -85.81 | -4.27 | -68.14 |
Other Financing Activities | 0.01 | - | - | -27.75 | -2.96 | -3.03 |
Financing Cash Flow | 92.15 | -71.09 | -53.69 | 873.44 | -31.54 | -18.78 |
Foreign Exchange Rate Adjustments | -0 | 0.01 | -0.05 | -0.08 | -0.08 | -0.25 |
Net Cash Flow | 20.13 | 84.52 | -351.14 | 669.17 | 44.12 | 13.9 |
Free Cash Flow | -63.42 | 20.78 | -106.48 | 58.94 | 75.38 | 32.41 |
Free Cash Flow Growth | - | - | - | -21.81% | 132.58% | -51.34% |
Free Cash Flow Margin | -9.40% | 2.88% | -14.00% | 7.52% | 11.53% | 4.57% |
Free Cash Flow Per Share | -0.15 | 0.05 | -0.25 | 0.15 | 0.24 | 0.11 |
Cash Income Tax Paid | 72.19 | 98.3 | 114.1 | 55.56 | 59.65 | 87.62 |
Levered Free Cash Flow | -38.25 | 82.8 | 10.05 | 23.05 | 43.07 | -34.81 |
Unlevered Free Cash Flow | -32.34 | 88.2 | 11.11 | 24.66 | 46.02 | -31.6 |
Change in Working Capital | -74.96 | -74.96 | -107.5 | -59.44 | -36.75 | -65.59 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.